LU75235A1 - - Google Patents

Info

Publication number
LU75235A1
LU75235A1 LU75235A LU75235A LU75235A1 LU 75235 A1 LU75235 A1 LU 75235A1 LU 75235 A LU75235 A LU 75235A LU 75235 A LU75235 A LU 75235A LU 75235 A1 LU75235 A1 LU 75235A1
Authority
LU
Luxembourg
Application number
LU75235A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75235A1 publication Critical patent/LU75235A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
LU75235A 1975-06-27 1976-06-24 LU75235A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU75235A1 true LU75235A1 (en:Method) 1977-03-16

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75235A LU75235A1 (en:Method) 1975-06-27 1976-06-24

Country Status (14)

Country Link
JP (1) JPS525764A (en:Method)
AT (1) AT365575B (en:Method)
BE (1) BE843505A (en:Method)
CH (1) CH623809A5 (en:Method)
DE (1) DE2528664A1 (en:Method)
DK (1) DK287476A (en:Method)
ES (1) ES449095A1 (en:Method)
FR (1) FR2316943A1 (en:Method)
GB (1) GB1553595A (en:Method)
IL (1) IL49916A0 (en:Method)
LU (1) LU75235A1 (en:Method)
NL (1) NL7606773A (en:Method)
SE (1) SE7607331L (en:Method)
ZA (1) ZA763802B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE423813B (sv) * 1976-08-06 1982-06-07 Pfizer Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
AU1293101A (en) 1999-12-22 2001-07-03 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
EA200300379A1 (ru) 2000-11-27 2003-08-28 Пфайзер Продактс Инк. Селективные агонисты рецептора ep4 в лечении остеопороза
EP1408961B1 (en) 2001-07-16 2007-07-11 F. Hoffmann-La Roche Ag 2 pyrrolidone derivatives as prostanoid agonists
MXPA04000456A (es) 2001-07-16 2004-03-18 Hoffmann La Roche Analogos de prostaglandina como agonistas del receptor ep4.
TWI313608B (en) 2001-07-23 2009-08-21 Ono Pharmaceutical Co Lower bone mass treating agent containing er4 agonist as active ingredient
JP2005531516A (ja) * 2002-03-18 2005-10-20 ファイザー・プロダクツ・インク 選択的ep4受容体アゴニストによる治療方法
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
BRPI0406717A (pt) 2003-01-10 2005-12-20 Hoffmann La Roche Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
HUE031885T2 (en) 2012-07-19 2017-08-28 Cayman Chemical Co Inc Difluoro lactam preparations for EP4-mediated osteo-related diseases and conditions
WO2014144610A1 (en) * 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
WO2014144500A2 (en) 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
EP3235817B1 (en) 2013-03-15 2018-12-12 Cayman Chemical Company, Incorporated Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
CA2910398A1 (en) 2013-07-19 2015-01-22 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Also Published As

Publication number Publication date
IL49916A0 (en) 1976-08-31
SE7607331L (sv) 1976-12-28
DK287476A (da) 1976-12-28
ATA467976A (de) 1981-06-15
JPS525764A (en) 1977-01-17
GB1553595A (en) 1979-09-26
FR2316943B1 (en:Method) 1978-11-03
DE2528664A1 (de) 1977-01-13
FR2316943A1 (fr) 1977-02-04
ZA763802B (en) 1977-05-25
CH623809A5 (en) 1981-06-30
ES449095A1 (es) 1977-12-16
NL7606773A (nl) 1976-12-29
AT365575B (de) 1982-01-25
BE843505A (fr) 1976-12-28

Similar Documents

Publication Publication Date Title
FR2316943B1 (en:Method)
FR2306876B1 (en:Method)
JPS5230330U (en:Method)
JPS5222074U (en:Method)
JPS557344B2 (en:Method)
JPS51112208U (en:Method)
JPS576184B2 (en:Method)
JPS5736424B2 (en:Method)
JPS5266099U (en:Method)
JPS5250886U (en:Method)
JPS5266896U (en:Method)
JPS5262313U (en:Method)
JPS5189523U (en:Method)
JPS5291826U (en:Method)
CH604746A5 (en:Method)
CH604670A5 (en:Method)
CH603921A5 (en:Method)
CH603813A5 (en:Method)
CH602889A5 (en:Method)
AU479572A (en:Method)
CH602134A5 (en:Method)
CH602064A5 (en:Method)
CH601612A5 (en:Method)
CH601117A5 (en:Method)
CH601005A5 (en:Method)